<DOC>
	<DOCNO>NCT02204163</DOCNO>
	<brief_summary>Evaluate efficacy safety treatment Eutropin® inj . compare Genotropin® infants/toddlers Prader-Willi syndrome</brief_summary>
	<brief_title>Study Assess Efficacy Safety Eutropin Prader-Willi Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prader-Willi Syndrome</mesh_term>
	<criteria>Genetically diagnose PraderWilli Syndrome Prepubertal start treatment ; assess Tanner stage 1 Known presence history malignancy Impaired Fasting Glucose Diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>